戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  calcium, vitamin D, protein, potassium, and soy isoflavones.
2 ms was evaluated as potential tool to purify soy isoflavones.
3 95% CI: 0.53, 0.86; p for trend = 0.001) for soy isoflavones.
4 o, -3.48 ppb [95% CI, -5.99 to -0.97 ppb] vs soy isoflavones, 1.39 ppb [95% CI, -1.73 to 4.51 ppb]) d
5 l Test (placebo, 1.98 [95% CI, 1.42-2.54] vs soy isoflavones, 2.20 [95% CI, 1.53-2.87]; positive valu
6 a control (placebo, 3.3 [95% CI, 2.7-4.1] vs soy isoflavones, 3.0 [95% CI, 2.4-3.7]), and changes in
7  finasteride together with the ERB agonists, soy isoflavones; 3) men with PCa above Gleason grade 4 (
8                       Evidence suggests that soy isoflavones act as estrogen agonists and have benefi
9  genistein, the major bioactive component of soy isoflavones, acts as a radiosensitizer and potentiat
10 ine excretion of glycitein compared to other soy isoflavones after a unique intake of food supplement
11 ether the protective effect of soy is due to soy isoflavones alone or to their combination with other
12                                              Soy isoflavones, although not as potent as risedronate,
13                      The HPLC conditions for soy isoflavone analysis were improved, leading to good s
14 of human intestinal bacterial synthesis from soy isoflavones and also show that both enantiomers are
15 cal studies investigating the combination of soy isoflavones and commonly used chemotherapeutic agent
16 l to evaluate interactive effects of dietary soy isoflavones and estrogen on risk markers for breast
17                              We examined how soy isoflavones and metabolites impact natural killer (N
18    In vivo treatment of prostate tumors with soy isoflavones and radiation down-regulated APE1/Ref-1
19 NA-binding activity of NF-kappaB mediated by soy isoflavones and radiation, thus promoting cell killi
20     We compared the in vitro effects of pure soy isoflavones and soy phytochemical concentrate on gro
21 , selenium, fish/marine omega-3 fatty acids, soy, isoflavones and polyphenols; whereas milk, dairy, c
22 ticals such as retinoids, botanicals such as soy isoflavones, and even moisturizers and sunscreen.
23 ion, allergens, and intake of acetaminophen, soy isoflavones, and polyunsaturated fatty acids, and ex
24                                              Soy isoflavones are being evaluated as chemopreventive a
25                                              Soy isoflavones are naturally occurring phytochemicals w
26                                              Soy isoflavones are potential cancer chemoprevention tre
27                                              Soy isoflavones are promising dietary agents for prevent
28    Epidemiological studies implicate dietary soy isoflavones as breast cancer preventives, especially
29                                              Soy isoflavones attenuated bone loss from the lumbar spi
30  primarily animal protein and one containing soy isoflavones before and after menopause may result in
31  Further, we assessed the effects of dietary soy isoflavones before or after ovariectomy.
32 of this study was to evaluate the effects of soy isoflavones, both in soymilk and in supplement form,
33 of the metabolites of daidzein, a well known soy isoflavone, but its chemopreventive activity and the
34                        Our data suggest that soy isoflavones can inhibit bladder tumor growth through
35 ether components of soy products or purified soy isoflavones can inhibit the progression of bladder c
36 bo-controlled trial to examine the effect of soy isoflavone capsules (80 mg/d of total isoflavones, 5
37 bjective of this study is thus to identify a soy isoflavone combination with lower levels of daidzein
38                           For treatment with soy isoflavone combination, genistein was always better
39 ic compounds and eleven bound phenolics in a soy isoflavone concentrate.
40 ty, and both of which were down-regulated by soy isoflavones, confirming the cross-talk between these
41    The present study examined the effects of soy isoflavone consumption on plasma concentrations of t
42                               The effects of soy isoflavone consumption on plasma total cholesterol,
43                   We describe the effects of soy isoflavone consumption on prostate specific antigen
44 ng-term effect of dietary soy protein and/or soy isoflavone consumption on skeletal health in late po
45             Development of a database of the soy isoflavone content of foods requires accurate and pr
46 rotein with normal (OVX+SOY) or reduced (OVX+SOY-) isoflavone content for 65 days.
47                                          The soy isoflavone daidzein is metabolized to equol and O-de
48 sively synthesize S-equol from the precursor soy isoflavone daidzein, and it is significant that, unl
49 sly reported that equol, a metabolite of the soy isoflavone daidzein, may advance breast cancer poten
50 ers contrasts with previous findings for the soy isoflavones daidzein and genistein, both of which ha
51                            Equol, unlike the soy isoflavones daidzein or genistein, has a chiral cent
52 recovery, we discovered that an FDA-approved soy isoflavone, daidzein, improved stroke-induced behavi
53                                              Soy isoflavones decreased APE1/Ref-1 expression in vitro
54 These data suggest that short-term intake of soy isoflavones did not affect serum hormone levels, tot
55                                              Soy isoflavones did not significantly affect calcium met
56 lly the concern for consumers taking regular soy isoflavone dietary supplements.
57 igh levels of phytoestrogens, in the form of soy isoflavones, during a stage of development at which
58  not show a bone-sparing effect of extracted soy isoflavones, except for a modest effect at the femor
59                                              Soy isoflavones exhibit a number of biological effects,
60 ontrolled intervention with a genistein-rich soy isoflavone extract (10mg/kg/day of genistein) follow
61 oflavone extracts and results were mixed for soy isoflavone extracts.
62                            Pretreatment with soy isoflavones followed by radiation inhibited APE1/Ref
63                                          The soy isoflavone genistein and the benzoquinonoid antibiot
64                                          The soy isoflavone genistein attenuates growth factor- and c
65                                              Soy isoflavone genistein exhibits growth inhibitory acti
66 ith those of other vitamin E analogs and the soy isoflavone genistein, a natural agonist of peroxisom
67                                          The soy isoflavones genistein and daidzein are found in bloo
68           The effects of resveratrol and the soy isoflavones genistein and daidzein on adipogenesis w
69 cause of potential estrogenic effects of the soy isoflavones genistein and daidzein.
70            The molecular mechanisms by which soy isoflavones (genistein, daidzein, and equol) afford
71 monstrated that dietary daidzein or combined soy isoflavones (genistein, daidzein, and glycitein) inc
72                                         Pure soy isoflavones (genistein, genistin, daidzein, and bioc
73     We investigated interactions between the soy isoflavone, genistein, and an antiestrogen, tamoxife
74  and 0.01 L (95% CI, -0.07 to 0.07 L) in the soy isoflavone group, which were not significantly diffe
75 s consisted of a placebo control group and 2 soy isoflavone groups (80 compared with 120 mg/d); women
76 cts receiving a daily supplement with 120 mg soy isoflavones had a statistically significant smaller
77 component of dietary fiber, total fruit, and soy isoflavones had the strongest associations.
78   Growing interest in the health benefits of soy isoflavones has led to research in the isolation of
79 cant interest in the mechanisms of action of soy isoflavones has predominantly stemmed from in vitro
80                        Although genistein, a soy isoflavone, has beneficial effects on various tissue
81                                              Soy isoflavones have antiestrogenic and anticancer prope
82                                              Soy isoflavones have antioxidant properties in vitro, bu
83 ne expression, and reduced blood pressure by soy isoflavones have implications for alternative therap
84                                              Soy isoflavones have numerous biological properties that
85                                              Soy isoflavones have variable effects on the prevention
86  changes following dietary intervention with soy isoflavones in healthy premenopausal women under con
87  drawn to the safety of using high levels of soy isoflavones in humans, which is especially the conce
88 ic effect, thereby providing a novel role of soy isoflavones in the regulation of insulin secretion.
89 been attributed to high soy diets, and major soy isoflavones, in particular daidzein and genistein, a
90                                              Soy isoflavones induce a G2-M cell cycle arrest in all h
91                                              Soy isoflavone intake (mg/d) was measured with validated
92                To study the relation between soy isoflavone intake and bone mineral density (BMD), th
93                 Despite large differences in soy isoflavone intake by country, isoflavone consumption
94 intake, as measured by either soy protein or soy isoflavone intake, was inversely associated with mor
95                                        Three soy isoflavone intakes (control: 10.0 +/- 1.1; low: 64.7
96                                  Daidzein, a soy isoflavone, is a clinically approved agent that has
97  Some data suggest that supplementation with soy isoflavone may be an effective treatment for patient
98                                     However, soy isoflavones may also have a role in promoting breast
99 presence of estrogen higher doses of dietary soy isoflavones may alter ER signaling and induce select
100                Potential mechanisms by which soy isoflavones might prevent atherosclerosis include a
101 de metastasis, which was not observed with a soy isoflavone mixture consisting of genistein, daidzein
102 licting results with regard to the effect of soy isoflavones on breast cancer risk.
103 m was to investigate the effects of isolated soy isoflavones on inflammatory biomarkers [von Willebra
104 e was to investigate the effects of isolated soy isoflavones on metabolic biomarkers of cardiovascula
105                         Interventions were 5 soy isoflavone oral supplements (2 doses of a genistein-
106  have been studied as receptors activated by soy isoflavones, perhaps explaining the lipid-lowering e
107 ctive of this study was to determine whether soy isoflavone phase II metabolism differs between human
108                                          The soy isoflavone phytoestrogens, genistein and daidzein, a
109  determine the molecular mechanisms by which soy isoflavones potentiate radiotherapy, we investigated
110 ed the bioconversion and bioaccessibility of soy isoflavones produced in sogurt fermented with S. the
111                Gut bacterial modification of soy isoflavones produces metabolites that differ in biol
112 rticipants were randomly assigned to receive soy isoflavone supplement containing 100 mg of total iso
113  did not significantly improve more with the soy isoflavone supplement than with placebo.
114 ile taking a controller medication, use of a soy isoflavone supplement, compared with placebo, did no
115 o and after control for pretreatment values, soy isoflavone supplementation had no effect on arginine
116              When compared with the placebo, soy isoflavone supplementation had no effect on changes
117 o protect against bone loss, the efficacy of soy isoflavone supplementation in the prevention of oste
118            Our aim was to test the effect of soy isoflavone supplementation on bone health.
119      The objective was to test the effect of soy isoflavone supplementation on nitric oxide productio
120                              The efficacy of soy isoflavone supplementation to stimulate nitric oxide
121                                              Soy isoflavone supplements are used to treat several chr
122         Use of soy-based infant formulas and soy/isoflavone supplements has aroused concern because o
123                               Genistein is a soy isoflavone that has antitumor activity both in vitro
124                      Bacterial metabolism of soy isoflavones varies among individuals.
125 on, while no consistent increase of the four soy isoflavones was determined.
126 terventions such as dietary and supplemental soy isoflavones were associated with improvement in dail
127  laboratory and animal studies reported that soy isoflavones were major bioactive compounds in soy to
128  human equivalent of 0, 60, 120, or 240 mg/d soy isoflavones with a dose of oral micronized 17beta-es
129            In an orthotopic model, combining soy isoflavones with tumor irradiation inhibited prostat

 
Page Top